"Bring Your Own Device" (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?

被引:19
作者
Gwaltney, Chad [1 ]
Coons, Stephen Joel [2 ]
O'Donohoe, Paul [3 ]
O'Gorman, Hannah [4 ]
Denomey, Matthew [5 ]
Howry, Cindy [6 ]
Ross, Jennifer [7 ]
机构
[1] Brown Univ, ERT, Providence, RI 02912 USA
[2] Crit Path Inst, PRO Consortium, Tucson, AZ USA
[3] CRF Hlth, London, England
[4] Exco InTouch, Nottingham, England
[5] ICON, Wurzburg, Germany
[6] YPrime, Austin, TX USA
[7] Almac Clin Technol, Souderton, PA USA
关键词
clinical outcome assessments; patient-reported outcomes; electronic data capture; smartphone apps; diaries; study endpoints; PRO INSTRUMENTS;
D O I
10.1177/2168479015609104
中图分类号
R-058 [];
学科分类号
摘要
Field-based patient-reported outcome (PRO) assessments, including measures of signs, symptoms, and events that are administered outside of the research clinic, can be critical in evaluating the efficacy and safety of new medical treatments. Collection of this type of data commonly involves providing subjects with stand-alone electronic devices, such as smartphones, that they can use to respond to assessments in their home or work environment. Although this approach has proven useful, it is also limited in several ways: For example, provisioning stand-alone devices can be costly for sponsors, and requiring subjects to carry a device that is exclusively dedicated to the study can be burdensome. The Bring Your Own Device (BYOD) approach, in which subjects use their own smartphone or Internet-enabled device to complete field-based PRO assessments, addresses many of these concerns. However, the BYOD model has its own limitations that should be considered. In this article, representatives of the ePRO Consortium review operational, privacy/security, and scientific/regulatory considerations regarding BYOD. We hope that this review will allow researchers to make informed decisions when choosing methods to collect field-based PRO data in future clinical trials. Additionally, we hope that the discussion in this article will establish a research agenda for further examination of BYOD approaches.
引用
收藏
页码:783 / 791
页数:9
相关论文
共 50 条
[41]   A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice [J].
Mercieca-Bebber R. ;
Friedlander M. ;
Calvert M. ;
Stockler M. ;
Kyte D. ;
Kok P.-S. ;
King M.T. .
Journal of Patient-Reported Outcomes, 1 (1)
[42]   Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making [J].
Jonathan R. Rees ;
Katie Whale ;
Daniel Fish ;
Peter Fayers ;
Valentina Cafaro ;
Andrea Pusic ;
Jane M. Blazeby ;
Fabio Efficace .
Journal of Cancer Research and Clinical Oncology, 2015, 141 :2181-2192
[43]   Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making [J].
Rees, Jonathan R. ;
Whale, Katie ;
Fish, Daniel ;
Fayers, Peter ;
Cafaro, Valentina ;
Pusic, Andrea ;
Blazeby, Jane M. ;
Efficace, Fabio .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) :2181-2192
[44]   15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis [J].
Paravathaneni, Mahati ;
Safa, Houssein ;
Joshi, Vidhu ;
Tamil, Monica K. ;
Adashek, Jacob J. ;
Ionescu, Filip ;
Shah, Savan ;
Chadha, Juskaran S. ;
Gilbert, Scott ;
Manley, Brandon ;
Semaan, Adele ;
Jim, Heather S. L. ;
Kalos, Denise ;
Kim, Youngchul ;
Spiess, Philippe E. ;
Chahoud, Jad .
ECLINICALMEDICINE, 2024, 68
[45]   A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms [J].
Brochmann, Nana ;
Zwisler, Ann-Dorthe ;
Kjerholt, Mette ;
Flachs, Esben Meulengracht ;
Hasselbalch, Hans Carl ;
Andersen, Christen Lykkegaard .
QUALITY OF LIFE RESEARCH, 2016, 25 (04) :835-846
[46]   A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms [J].
Nana Brochmann ;
Ann-Dorthe Zwisler ;
Mette Kjerholt ;
Esben Meulengracht Flachs ;
Hans Carl Hasselbalch ;
Christen Lykkegaard Andersen .
Quality of Life Research, 2016, 25 :835-846
[47]   Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory [J].
Loubert, Angely ;
Regnault, Antoine ;
Sebille, Veronique ;
Hardouin, Jean-Benoit .
BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22 (01)
[48]   Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory [J].
Angély Loubert ;
Antoine Regnault ;
Véronique Sébille ;
Jean-Benoit Hardouin .
BMC Medical Research Methodology, 22
[49]   A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia [J].
Jill A. Bell ;
Aaron Galaznik ;
Farrah Pompilus ;
Sara Strzok ;
Rafael Bejar ;
Fatima Scipione ;
Robert J. Fram ;
Douglas V. Faller ;
Stefan Cano ;
Patrick Marquis .
Journal of Patient-Reported Outcomes, 3
[50]   A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia [J].
Bell, Jill A. ;
Galaznik, Aaron ;
Pompilus, Farrah ;
Strzok, Sara ;
Bejar, Rafael ;
Scipione, Fatima ;
Fram, Robert J. ;
Faller, Douglas, V ;
Cano, Stefan ;
Marquis, Patrick .
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3 (01)